SBIR/STTR Research Award

Non-invasive prenatal testing of sickle cell disease

Award identifier 44ece731897c5ffde3c0d595f7cf95e33d8981c13d14ed17c9db584bca3ecab5Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$224,227

Program and phase

SBIR · Phase I

Award year

2018

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
BillionToOne, Inc.
Proposal award date
2018-09-20
Contract end date
2019-08-31
UEI
Not reported
Solicitation number
PA17-302
Topic code
NHLBI

Research abstract

Overinfants are born with sickle cell diseaseSCDevery year world wideincluding at leastin the USPrenatal diagnosis by amniocentesis or chorionic villus sampling is availablebut high costinvasivenessand risk of miscarriage limit their useThis Phase I SBIR project will show feasibility of a noninvasive test for Sickle Cell Disease that is affordable and completely safe to useBy finding their child s SCD status before birthparents can opt for umbilical cord blood banking to save their child s stem cellsThese stem cells could be critical for access to future gene therapy SCD cures that are in clinical trials and will likely become approved in the nextyearsOur non invasive prenatal test uses the cell free DNA that a developing fetus sheds into the mother s bloodstreamBy taking peripheral blood sample from a pregnant womanour assay is able to determine the fetal genotype for sickle cell disease causing mutationsTo support this assaywe have developed innovative probes for sickle cell alleles that can measure allele fractions with coefficient of variation andltthrough the use of nextgeneration DNA sequencingThis project will demonstrate the feasibility of our approach for non invasive prenatal testing of sickle cell disease through the following specific aimsSpecific AimValidate optimized probes for HBB on cfDNA isolated from healthy SCT individualsSpecific AimIdentify the fetal HBB genotypee gHbASHbSCor HbSSfrom pregnant women who have SCDAimIdentify the fetal SCD genotypee gHbAAHbASHbSCor HbSSof pregnant women who have SCT This proposal aims to develop a non invasive prenatal test for sickle cell diseasewhich is the most common genetically inherited disorder in the worldPrenatal testing for sickle cell disease supports gene therapy cures by identifying when umbilical cord blood banking should be performedThis Phase I SBIR will demonstrate the feasibility of non invasive prenatal testing for sickle cell disease by performing the test on patients at high risk for having an affected child

Technology keywords

Not reported

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.